Publications by Janzer, Robert C.

Stupp, Roger, Hegi, Monika E., Mason, Warren P., van den Bent, Martin J., Taphoorn, Martin J. B., Janzer, Robert C., Ludwin, Samuel K., Allgeier, Anouk, Fisher, Barbara, Belanger, Karl, Hau, Peter, Brandes, Alba A., Gijtenbeek, Johanna, Marosi, Christine, Vecht, Charles J., Mokhtari, Karima, Wesseling, Pieter, Villa, Salvador, Eisenhauer, Elizabeth, Gorlia, Thierry, Weller, Michael, Lacombe, Denis, Cairncross, J. Gregory and Mirimanoff, René-Olivier (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The lancet oncology 10 (5), pp. 459-466. Fulltext not available.

Hegi, Monika E., Diserens, Annie-Claire, Gorlia, Thierry, Hamou, Marie-France, de Tribolet, Nicolas, Weller, Michael, Kros, Johan M., Hainfellner, Johannes A., Mason, Warren, Mariani, Luigi, Bromberg, Jacoline E. C., Hau, Peter, Mirimanoff, René O., Cairncross, J. Gregory, Janzer, Robert C. and Stupp, Roger (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. The New England journal of medicine 352 (10), pp. 997-1003. Fulltext not available.

Stupp, Roger, Mason, Warren P., van den Bent, Martin J., Weller, Michael, Fisher, Barbara, Taphoorn, Martin J. B., Belanger, Karl, Brandes, Alba A., Marosi, Christine, Bogdahn, Ulrich, Curschmann, Jürgen, Janzer, Robert C., Ludwin, Samuel K., Gorlia, Thierry, Allgeier, Anouk, Lacombe, Denis, Cairncross, J. Gregory, Eisenhauer, Elizabeth and Mirimanoff, René O. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine 352 (10), pp. 987-996. Fulltext not available.